Original language | English |
---|---|
Pages (from-to) | 297-298 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 398 |
Issue number | 10297 |
Early online date | 7 Jul 2021 |
DOIs | |
Publication status | Published - 24 Jul 2021 |
Bibliographical note
Funding Information:JD, ZHa, MM, SM, CP, AR, and SR are members of Independent SAGE. SR is a member of the advisory group to the Scottish Chief Medical Officer. RW, SM, SR, and JD are participants in the Independent Scientific Pandemic Insights Group on Behaviours, the behavioural science subgroup of SAGE. JD declares funding for research on public behaviour in the pandemic, paid to the University of Sussex, from the Economic and Social Research Council (ESRC) and fees from the BBC and The Guardian for media appearances and articles. SG declares research grants from the Medical Research Council (MRC) and the AMMF and fees from Hallmark Care Homes for webinars about vaccine hesitancy. SG is also a member of the UK Government's COVID-19 Expert Panel on Home Testing and the COVID-19 International Best Practice Advisory Group, and he is a consultant on shielding for the International Comparators Joint Unit (IBPAG-ICJU). SG is Chair of the Virus Division of the Microbiology Society and a member of the British Society for Antimicrobial Chemotherapy grants review panel. SM declares research grants from the MRC, the ESRC, the Wellcome Trust, Cancer Research UK, and the National Institutes of Health Research and fees from the BBC and ITN for media appearances. All other authors declare no competing interests. A summit to discuss the concerns outlined in this Correspondence will take place on July 8, 2021. Signatories of this Correspondence are listed in the appendix .
Keywords
- Mass infection
- Herd immunity
- Vaccination
- COVID-19